New Delhi, Dec 27 (PTI) Aurobindo Pharma today said it has received final approval from the US health regulator to manufacture and market its generic version of Fondaparinux Sodium injection used to ...

Fondaparinux binds only to antithrombin and has little affinity for platelet factor 4, thereby having a low likelihood of causing HIT. [28,29] Although clinical trial data are lacking, ACCP guidelines ...

HYDERABAD, India & BRISBANE, Australia--(BUSINESS WIRE)--Dr. Reddy’s Laboratories (NYSE: RDY) and Alchemia Limited, Brisbane, Australia (ASX: ACL) announced today that Dr. Reddy’s has received final ...

Bullous hemorrhagic dermatosis is an uncommon nonimmune adverse drug reaction to heparin-based anticoagulants including unfractionated heparin, low-molecular-weight heparin and fondaparinux that ...

Review the side-effects of Fondaparinux as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of ...

Details concerning the Fondaparinux medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, liquids, and injections ...

Fondaparinux sodium, a synthetic pentasaccharide, is a selective inhibitor of factor Xa, binding selectively with high affinity to antithrombin III, specifically catalyzing the inactivation of factor ...

Aurobindo Pharma today said it has received final approval from the US health regulator to manufacture and market its generic version of Fondaparinux Sodium injection used to prevent deep vein ...